Differential indication of induction treatment in non-small-cell-lung-cancer;Differentialindikation zur Induktionstherapie bei nicht-kleinzelligen Lungentumoren

Chirurg

Volumn 71, Issue 12, 2000, Pages 1466-1473

  Drings, P ^a   Manegold, Ch ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Induction chemo radiotherapy; Induction chemotherapy; Multimodal treatment; Non small cell lung cancer

Indexed keywords

ADJUVANT THERAPY; CANCER STAGING; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHASE 2 CLINICAL TRIAL; REVIEW; SURVIVAL RATE; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PNEUMONECTOMY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034572131     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040051245     Document Type: Article

References (76)

1. Albain K, Rush V, Crowley I, Griffin B, et al (1991) Concurrent Cisplatin (DDP), Vp-16, and chest irradiation (RT) followed by surgery for stages IIIa and IIIb non small cell lung cancer (NSCLC) A Southwest Oncology Groups (SWOG study (#8805). Proc Am Soc Clin Oncol 10: 244 (A836)
2. Albain KS, Rush VW, Crowley JJ, Rice TW, et al (1995) Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage IIIA (N2) and IIIB non-small cell lung cancer: major results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13: 1880
3. Albain KS (1999) Induction chemotherapy with or without radiotherapy followed by surgery in non-small cell lung cancer. In: Van Houtte P, Klastersky J, Roscman P (eds) Progress and perspectives in the treatment of lung cancer. Springer, Berlin Heidelberg New York, p 53
4. Betticher DC, Hasu Schmitz SF, Gauthier Y, et al (1999) Neo-adjuvant chemotherapy with docetaxel and cisplatin in patients with non-small cell lung cancer stage IIIA, N2 is highly active with few toxicities. Proc Am Soc Clin Oncol 18: 473 (A1824)
5. Bitran JD, Golomb HM, Hoffmann PC, Albain K, et al (1986) Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival: a preliminary report. Cancer 57:44
6. Bleehen NM (1991) Combined radiotherapy with chemotherapy for inoperable non-small cell lung cancer. Lung Cancer 7: 85
7. Bonomi P, Trybulla M, Sander S, Taylor S, et al (1986) Comparison of neoadjuvant chemotherapy (Neo-CT) alone to simultaneous chemotherapy (SCT-RT) in locally advanced squamous cell bronchogenic carcinoma (sq CBS). Neo-adjuvant chemotherapy. Coll. INSERM/ John Libbey Eurotext 137: 505
8. Bülzebruck H, Bopp R, Drings P, Bauer E, et al (1992) New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM-classification. Cancer 70: 1102
9. Burkes RL, Shepherd FA, Ginsberg RJ, Blackstein ME, et al (1994) Induction chemotherapy with MVP in patients with stage IIIa (T1-3, N2, M0) unresectable non-small cell lung cancer (NSCLC): the Toronto Experience. Proc Am Soc Clin Oncol (Abstract) 13: 327
10. Chapman R, Lewis J, Kvale P, Lehmann'D, et al (1990) A neoadjuvant trial in stage II and stage IIIa non-small cell lung cancer with cisplatinum and vinblastine chemotherapy. Proc Am Soc Clin Oncol 9: 246 (A954)
11. Choy H, Akerley W, Safran H, Graziano S, et al (1997) Phase II trial of weekly paclitaxel, carboplatin and concurrent radiationtherapy for locally advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 16: 456 (A1637)
12. Cigolari S, Curcio C, Massimo M, Sessa R, et al (1998) Vinorelbine/ cisplatin combination neo-adjuvant chemotherapy in stage IIIB non-small cell lung cancer: results after 2 years. Lung Cancer 21 [Suppl 1]: 53 (abstract)
13. Clamon G, Herndon J, Cooper R, Chang AY, et al (1999) Radiosensitization with carboplatin for patients with unresectable stage III non-small cell lung cancer: a phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 17: 4
14. Clavier J, Zabbè CL, Raut Y, Briere J, et al (1986) Chimiothérapie preopératoir dans le cancera bronchiques epidermoides. Résultats d'une étude pilote portant sur 60 patients. Neo-adjuvant chemotherapy, Coll. INSERM/John Libbey Eurotext 137: 473
15. Cox JD (1991) The respective roles of radiation therapy and chemotherapy in non small cell carcinoma of the lung with mediastinal but not distant metastasis (N2 M0). Lung Cancer 7: 65
16. Dillman RO, Seagren SL, Propert KJ, Guerra J, et al (1990) A randomised trial of induction chemotherapy plus high-dose radiation versus radiation in stage III non-small cell lung cancer. N Engl J Med 323: 940
17. Drings P, Wannenmacher M (1998) Nicht-kleinzellige Bronchialkarzinome. In: Seeber S, Schütte J (Hrsg) Therapiekonzepte Onkologie, 3. vollst, überarb. erw. Aufl. Springer, Berlin Heidelberg New York,S 526
18. Eagan RT, Ruud C, Lee R, Pairolero PC, Gail MH (1987) For the lung cancer study group: a pilot study of induction therapy with cyclophosphamide, doxorubicin, cisplatinum (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III M0 non small cell lung cancer. Cancer Treat Rep 71: 895
19. Eberhardt W, Wilke H, Stamatis G, Stuschke M, et al (1998) Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial. J Clin Oncol 2: 622
20. Elias AD, Herdon J, Kumar P, Shugarbaker D, Green MR for the Cancer and Leukemia Group B (1997) A phase III comparison of "best local-regional therapy" with or without chemotherapy for stage IIIA T2-3 N2 non-small cell lung cancer: preliminary results. Proc Am Soc Clin Oncol 16: 448 (A1611)
21. Edelmann JM, Gandara DR, Roach M, Benfield J (1996) Multimodality therapy in stage III non-small cell lung cancer. Ann Thorac Surg 61: 1564
22. Fischer JR, Manegold Ch, Bülzebruck H, Vogt-Moykopf I, Drings P (1994) Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage III A/B non-small cell lung cancer. Semin Oncol 21 [Suppl 4]: 20
23. Furuse K, Fukuoka M, Takada Y, Nishikawa H, et al (1999) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer: 5-year median follow-up results. Proc Am Soc Clin Oncol 18: 458 (A1770)
24. Gandara DR, Leigh B, Vallieres E, Albain KS (1999) Preoperative chemotherapy in stage III non-small cell lung cancer: long-term outcome. Lung Cancer 26: 3
25. Hazuka MB, Bunn P (1992) Controversies in the non surgical treatment of stage III non-small cell lung cancer. Am Rev Respir Dis 145: 967
26. Henriques I, Munoz-Galindo L, Rebello J, Vieitez JM, et al (1990) Neoadjuvant chemotherapy (NAC) with cisplatin (CDDP), mitomycin C (MMC) and vindesine (VDS) in locally advanced non small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1: 227 (A876)
27. Holmes EC, Gail M (1986) Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell, undifferentiated carcinoma. J Clin Oncol 4: 710
28. Israel I, Breau JL, Morère JM (1986) Chimiothérapie pré-opératoire dans 57 cas de cancers bronchiques épidermoides. Analyse des responses des complications et de la survie. Neoadjuvant chemotherapy. Coll INSERM/John Libbey, Eurotext 137: 463
29. Jeremic B, Shibamoto Y, Acimovic I, Milisavljevic S (1996) Hyperfractionated radiation therapy with or without concurrent low-dose carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. J Clin Oncol 14: 1065
30. Johnson DH, Turrisi A, Pass HI (1996) Combined-modality treatment for locally advanced non-small cell lung cancer, chap 59. In: Pass HI, Mitchel JB, Johnson DH, Turrisi AT (eds) Lung cancer: principles and practice. Lippincott-Raven, Philadelphia, S 863
31. Kenis Y (1980) Surgical adjuvant chemotherapy in non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 6: 1075
32. Kris MG, Gralla RJ, Martini M, Stampleman LV, Burke MT (1987) Preoperative and adjuvant chemotherapy in locally advanced non-small cell lung cancer. Surg Clin N Am 67: 1051
33. Kraut MJ, Rusch VW, Crowley JJ, Gandara DR, Wayne State University, Detroit/MI, Memorial Sloan-Kettering Cancer Center, New York/ NY, Southwest Oncology Group, Seattle/WA, University of California Davis Cancer Center, Sacramento/CA (2000) Induction chemoradiation plus surgical resection is a feasible and highly effective treatment for pancoast tumors: initial results of SWOG 9416 (Intergroup 0160) trial. Proc Am Soc Clin Oncol 19: 487 (A1906)
34. Laack E, Hossfeld DK (2000) Therapie des nicht-kleinzelligen Bronchialkarzinoms. Eine interdisziplinäre Herausforderung. Dtsch Ärzteblatt 97: 330
35. Lad T, Rubenstein L, Sadeghi A (1988) The benefit of adjuvant treatment for resected locally advanced non small cell lung cancer. J Clin Oncol 6: 9
36. Le Chevalier T, Arriagada R, Quiox E, Ruffie P, et al (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in non resectable non-small cell lung cancer: first analysis of a randomised trial in 353 patients. Natl Cancer Inst 83: 417
37. Legha SS, Muggia FM (1979) Adjuvant chemotherapy in lung cancer; an appraisal of past studies. In: Muggia FM, Rozencweig (eds) Lung cancer, progress in therapeutic research. Raven, New York, p 405
38. Loonbey WB, Goldie JH, Little JB, Hopkins HA, et al (1985) Alternating of chemotherapy and radiotherapy in cancer management. 1. Summary of the division of cancer treatment workshop. Cancer Treat Rep 69: 769
39. Martini N, Kris MG, Gralla RJ, Bains MS, et al (1988) The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2M0). Ann Thorac Surg 45: 370
40. Martini N, Kris MG, Flehinger BJ, Gralla RJ, et al (1993) Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 55: 1365
41. Mountain CF (1998) Value of the new TNM staging system for lung cancer. Chest 96 (Suppl 1): 47
42. Naruke T, Goya T, Tsuchiya R, Suemasu K (1988) Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96: 440
43. O'Brien M, Smith IE, Postmus PE, Smith E, et al for the EORTC-LCCG (1999) Taxol and carboplatin induction chemotherapy in stage IIIA non-small cell lung cancer: An EORTC 08958 phase II trial. Proc Am Soc Clin Oncol 18: 942 (A 1898)
44. Pass HI, Pogrebniak HW, Steinberg SM, Mulshine J, Minna JD (1992) Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 53: 992
45. Perez CA, Stanley K, Rubin P, Kramer S, et al (1980) Patterns of tumor recurrence after definitive irradiation for inoperable non-oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 6: 987
46. Perry MC, Deslauriers J, Albain KS, Choi NC, et al (1997) Induction treatment for resectable non-small cell lung cancer: a consensus report. Lung Cancer 17: 15
47. Pinkus M, Reddy S, Lee MS, Bonomi P, et al (1988) Preoperative combined modality therapy for stage III M0 non small cell lung carcinoma. Int J Radiat Oncol Biol Phys 15: 189
48. Pisters KMW, Kries MG, Gralla RJ, Martini N (1990) Preoperative chemotherapy in stage IIIA non-small cell cancer: an analysis of a trial in patients with clinically apparent mediastinal node involvement. In: Salmon SE (ed) Adjuvant chemotherapy of cancer IV. Saunders, Philadelphia, p 133
49. Pujol JL, Rossi JF, Le Chevalier T, Daurès JP, et al (1990) Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer. Eur J Cancer 26:798
50. Rebello J, Aramendia JM, Bilbao I, Herreros J, Aristu JJ, et al (1993) Neoadjuvant intra-arterial (IA) chemotherapy for stage III non small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 12: 346 (A1161)
51. Rice TW, Adelstein DJ, Bäcker M, Larto MA, Kirbey TJ (1997) Stage III non-small cell lung cancer: short course multimodality treatment with accelerated fractionation radiation, concurrent cisplatin/paclitaxel chemotherapy and surgery. Lung Cancer 18 [Suppl 1]: 64
52. Rosell R, Gomez-Godina J, Camps C, Mastre J, et al (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 333: 153
53. Rosell R (1998) The integration of newer agents into neoadjuvant therapy. Semin Oncol 25: 24
54. Rosell R, Gómez-Codina J, Camps C, Sánchez JJ, et al (1999) Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 47: 7
55. Roth JA, Fossella F, Komaki R, Ryan MB, et al (1994) A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III non-small cell lung cancer. Natl Cancer Inst 86: 673
56. Roth JA, Atkinson EN, Fossella F, Komaki R, et al (1998) Longterm follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 21: 1
57. Sandler AB, Buzaid AC (1992) Lung cancer: a review of current therapeutic modalities. Lung 170:249
58. Sause W, Scott C, Taylor S, Johnson D, et al (1994) RTOG 8808 ECOG 4588. Preliminary analysis of a phase II trial in regionally advanced unresectable non-small cell lung cancer. Proc Am Assoc Clin Oncol 13: 325 (Abstract)
59. Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, von Houtte P, Kirkpatrick A, Koolen M, et al (1992) Effects of concomitant cisplatin and radiotherapy in inoperable non-small cell lung cancer. N Engl J Med 326: 524
60. Schirren J, Muley T, Schneider P, Latzke L, et al (1998) Chirurgische Therapie des Bronchialkarzinoms. In: Drings P, Vogt-Moykopf I (Hrsg) Thoraxtumoren. Diagnostik, Staging, gegenwärtiges Therapiekonzept, 2. Aufl. Springer, Berlin Heidelberg New York, S 232
61. Spain R (1988) Neoadjuvant mitomycin C, cisplatin, and infusion vinblastine in locally and regionally advanced non-small cell lung cancer: problems and progress rom the perspective of long-term follow-up. Semin Oncol 15 [Suppl 4]: 6
62. Skarin A, Jochelson M, Sheldon T, Malcom A, et al (1989) Neoadjuvant chemotherapy in marginally in resectable stage III MO non small cell lung cancer. Long-term follow-up in 41 patients. J Surg Oncol 40: 266
63. Splinter TAW, Kirkpatrick A, Darwish S, van Meerbeeck J for the EORTC, GOIRC and VKSL (1997) Randomized trial of surgery versus radiotherapy after a response to induction chemotherapy. Intergroup Study 08941. Lung Cancer 18: 62
64. Stewart IA, Pignon JP for Non-small Cell Cancer Cooperative Group (1995) Chemotherapy in non-small cell lung cancer: a metaanalysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311: 899
65. Strauss G, Sherman D, Schwartz J (1986) Combined modality therapy for regionally advanced stage III non small cell carcinoma of the lung employing neoadjuvant chemotherapy, radiotherapy and surgery. Proc Am Soc Clin Oncol 5: 172 (A675)
66. Strauss GM, Herndon JE, Sherman DD, Mathisen DJ, et al (1996) Induction chemoradiation followed by surgery in stage IIIA non-small cell carcinoma of the lung: long-term results of Cancer and Leukemia Group B protocol 8634. Proc Am Soc Clin Oncol 15: 376 (A1121)
67. Sugarbaker DJ, Herndon J, Decamp MM, Jaklitsch MT, et al (1998) N2 status at resection predicts long-term outcome following induction therapy for stage IIIa non-small cell lung cancer: CALGB 8935. Proc Am Soc Clin Oncol 17: 452
68. Takita H, Regal AM, Antkowiak JG, Rao UNM, et al (1986) Chemotherapy followed by lung resection in inoperable non-small cell lung carcinoma due to locally far-advanced disease. Cancer 57: 630
69. Takita H, Antkowiak J, Vaickus L, Driscoll D, et al (1993) Che-mo-therapy (PACC) and surgery in stage III NSCLC. Proc Am Soc Clin Oncol 12: 349 (A1172)
70. Thomas M, Rübe C, Semik M, von Eiff M, et al (1999) Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small cell lung cancer. J Clin Oncol 17: 1185
71. Tubiana M, Arriagada R, Cosset JM (1985) Sequencing of drugs and radiation. Cancer 55: 2131
72. Trybulla M, Taylor SG, Bonomi P (1985) Preoperative similtaneous cisplatin/5-fluorouracil and radiotherapy in clinical stage III, non small cell bronchogenic carcinoma. Proc Am Soc Clin Oncol 4: 182 (A710)
73. Von Zandwijk N, Smit EF, Kramer GWP, Schramel F, et al (2000) Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a Phase II study of the European Organization for Research and Treatment of Cancer, Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol: 18: 2658
74. Weitberg AB, Yahar J, Glicksman AS, Posner A, et al (1993) Combined modality therapy for stage III A non small cell carcinoma of the lung. Eur J Cancer 29A: 511
75. Weiden P, Piantadosi S (1991) Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer: a phase II study of the Lung Cancers Study Group. J Natl Cancer Inst 83: 266
76. Wolf M, Hans K, Becker H, Hässler R, et al (1994) Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small-cell lung cancer. Semin Oncol 21 [Suppl 4]: 42